FreeOx’s Ox-01 to be Tested as Thrombectomy Therapy for Stroke in NINDS
January 3, 2025
FreeOx Biotech, a clinical stage biopharmaceutical company pioneering the development of a novel drug class for Acute Ischemic Stroke (AIS), announced that its lead compound,